Need a specific person's email?
Browse Rubius Therapeutics's employee directory (about 18 employees) and reveal verified emails free.
Rubius Therapeutics's most common email format is First.Last@rubiustx.com (ex. John.Doe@rubiustx.com), used for 87% of rubiustx.com addresses. Rubius Therapeutics uses 4 email patterns.
| Format | Example | Share of rubiustx.com |
|---|---|---|
| First.Last@rubiustx.comMost common | John.Doe@rubiustx.com | |
| First@rubiustx.com | John@rubiustx.com | |
| FLast@rubiustx.com | JDoe@rubiustx.com | |
| First.MiddleLast@rubiustx.com | John.MichaelDoe@rubiustx.com |
Browse Rubius Therapeutics's employee directory (about 18 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States11-50 Employees
Rubius Therapeutics is a biotechnology company focused on cellular medicines. It has created a platform to engineer and culture Red Cell Therapeutics for use as cellular therapies, pursuing two modalities aimed at cancer and autoimmune diseases. The company’s early clinical program includes RTX-240 in Phase 1/2 trials for advanced solid tumors, with a monotherapy arm and a pembrolizumab combination arm; the combination arm was expanded in 2022 to cover non-small cell lung cancer and renal cell carcinoma. A second program, RTX-224, targets several advanced solid tumors, including non-small cell lung cancer, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial carcinoma, and triple-negative breast cancer.
Most common format
First.Last@rubiustx.com
Example: John.Doe@rubiustx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.